Markey’s Community Advisory Board advocates for research advances
Video produced by UK Markey Cancer Center Community Impact Office. To view captions for this video, push play and click on the CC icon in the bottom right-hand corner of the screen. If using a mobile device, click on the “thought bubble” in the same area.
LEXINGTON, Ky. (May 30, 2025) – For more than 30 years, Jack Hillard has been a patient at the University of Kentucky Markey Cancer Center. First diagnosed with a rare form of leukemia, he later developed early-stage colon cancer and skin cancer. Today, at 65, the Lexington resident leads an active, healthy life thanks to treatment he received at Markey — treatment made possible through research.
“I can’t imagine anything more exciting than being part of a new research breakthrough,” said Hillard. “Multiple members of my family have had cancer in previous generations, but I’m hoping that my nieces and nephews won’t have to go through what they have due to a new research breakthrough.”
Hillard now serves on Markey’s Community Advisory Board (CAB) as a representative for Central Kentucky. He is one of a dozen Kentuckians from across the state who make up the CAB, which advises Markey Cancer Center Director B. Mark Evers, M.D., on Markey research and outreach activities and ensures that the center serves the needs of communities throughout Kentucky.
Hillard and other CAB members recently shared their perspectives on the importance of cancer research in a new video highlighting the board’s advocacy work.
For Hillard, serving on the board is his way of “paying it back and paying it forward.” Research advancements made it possible for him to take a drug that successfully keeps his leukemia in check. And he continues with quarterly checkups with his hematologist at Markey.
Led by Markey’s Community Impact Office, the CAB meets regularly throughout the year. Members have joined lab tours, met with researchers and provided feedback on research projects. They also offered input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.
As CAB members learn more about cancer research at Markey, they’ve become passionate advocates for more people to participate in cancer research. Many of them, like Hillard, are survivors or caregivers who understand firsthand how advances in prevention, screening, treatment and survivorship research have reduced the burden of cancer and saved lives.
“CAB members share what they learn with their friends, families and neighbors,” said Pamela Hull Ph.D., Markey’s associate director of Population Science and Community Impact. “They help to spread the word about how cancer research can benefit their communities across Kentucky.”
Clinical studies are vital to advancing cancer care. Markey offers numerous clinical studies that give patients access to innovative treatments and therapies that aren’t yet widely available. Patient participation in these studies is critical not only for individual treatment options but also for developing better approaches to cancer prevention, detection and treatment that will benefit future generations.
“Supporting cancer research is both a moral imperative and a smart investment in our future,” Hillard said. “The treatments that are helping me today will be replaced by even better therapies for future generations. We need to maintain our momentum in research to ensure the next generation has better options than what’s available today.”
Learn more about Community Impact Office activities and Markey clinical studies, or sign up for research study announcements.
UK HealthCare is the hospitals and clinics of the University of Kentucky. But it is so much more. It is more than 10,000 dedicated health care professionals committed to providing advanced subspecialty care for the most critically injured and ill patients from the Commonwealth and beyond. It also is the home of the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, a Level IV Neonatal Intensive Care Unit that cares for the tiniest and sickest newborns, the region’s only Level 1 trauma center and Kentucky’s top hospital ranked by U.S. News & World Report.
As an academic research institution, we are continuously pursuing the next generation of cures, treatments, protocols and policies. Our discoveries have the potential to change what’s medically possible within our lifetimes. Our educators and thought leaders are transforming the health care landscape as our six health professions colleges teach the next generation of doctors, nurses, pharmacists and other health care professionals, spreading the highest standards of care. UK HealthCare is the power of advanced medicine committed to creating a healthier Kentucky, now and for generations to come.